• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血浆的体外核磁共振波谱未能检测出早期乳腺癌。

Failure to detect early breast cancer using in vitro nuclear magnetic resonance spectroscopy of plasma.

作者信息

Holmberg L, Jakobsson U, Berglund A, Adami H O

机构信息

Department of Surgery, University Hospital, Uppsala, Sweden.

出版信息

Br J Cancer. 1993 Aug;68(2):389-92. doi: 10.1038/bjc.1993.346.

DOI:10.1038/bjc.1993.346
PMID:8347495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1968536/
Abstract

Water suppressed proton nuclear magnetic resonance (1H NMR) spectroscopy of human plasma has been described as successful in detection of malignancy. We designed a prospective study to test the hypothesis that in vitro NMR spectroscopy has a high sensitivity for detecting early breast cancer. One hundred and thirty-five women were referred for breast biopsy due to abnormal mammograms. One hundred of these were recruited through a population-based mammography screening project. Sixty-nine of 135 women were found to have breast cancer and their average line width of the methyl and methylene resonance in the plasma were compared to those women who had a benign or normal histopathology in the biopsy and to the line width for 100 healthy subjects from the same population. The mean line width at a half-height of the methyl and methylene resonances of the serum lipoprotein lipids in the NMR spectrum did not differ appreciably between the groups. The line width correlated highly with the serum triglycerides, but correction for the level of triglycerides did not improve the diagnostic accuracy of the line width. Receiver-operating characteristic analysis revealed a sensitivity of 61% and a false positive rate of 43% at the most beneficial cut-off of line width (39.7 Hz). In vitro NMR spectroscopy in our hands was thus not a useful diagnostic tool in patients with early breast cancer.

摘要

人体血浆的水抑制质子核磁共振(1H NMR)光谱法已被描述为在检测恶性肿瘤方面取得了成功。我们设计了一项前瞻性研究,以检验体外NMR光谱法在检测早期乳腺癌方面具有高灵敏度这一假设。135名女性因乳房X光检查异常而被转诊进行乳房活检。其中100名是通过基于人群的乳房X光筛查项目招募的。135名女性中有69名被发现患有乳腺癌,她们血浆中甲基和亚甲基共振的平均线宽与活检中组织病理学为良性或正常的女性以及来自同一人群的100名健康受试者的线宽进行了比较。NMR光谱中血清脂蛋白脂质的甲基和亚甲基共振半高处的平均线宽在各组之间没有明显差异。线宽与血清甘油三酯高度相关,但对甘油三酯水平进行校正并没有提高线宽的诊断准确性。受试者操作特征分析显示,在线宽最有利的截断值(39.7 Hz)时,灵敏度为61%,假阳性率为43%。因此,在我们手中,体外NMR光谱法对早期乳腺癌患者并不是一种有用的诊断工具。

相似文献

1
Failure to detect early breast cancer using in vitro nuclear magnetic resonance spectroscopy of plasma.利用血浆的体外核磁共振波谱未能检测出早期乳腺癌。
Br J Cancer. 1993 Aug;68(2):389-92. doi: 10.1038/bjc.1993.346.
2
Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.血浆中亚甲基和甲基线宽的质子核磁共振波谱测量:与乳腺癌程度、孕期时长及衰老的显著差异
NMR Biomed. 1991 Jun;4(3):142-9. doi: 10.1002/nbm.1940040306.
3
Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测。血浆的水抑制质子核磁共振波谱分析。
N Engl J Med. 1986 Nov 27;315(22):1369-76. doi: 10.1056/NEJM198611273152201.
4
Early changes in the 1H-NMR plasma spectrum in patients following breast surgery.乳腺癌手术后患者血浆1H-NMR谱的早期变化。
Eur J Surg Oncol. 1993 Apr;19(2):115-22.
5
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.血浆水抑制质子核磁共振波谱法检测恶性肿瘤的效能不足。
N Engl J Med. 1990 Apr 5;322(14):953-8. doi: 10.1056/NEJM199004053221403.
6
Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy.乳腺癌患者内分泌治疗期间的血浆变化——血脂测定与核磁共振光谱分析
Breast Cancer Res Treat. 1995;36(3):287-97. doi: 10.1007/BF00713400.
7
Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.恶性肿瘤中血浆脂蛋白的质子核磁共振波谱分析
Acta Oncol. 1988;27(5):479-82. doi: 10.3109/02841868809093574.
8
C-13 NMR spectroscopy of plasma reduces interference of hypertriglyceridemia in the H-1 NMR detection of malignancy. Application in patients with breast lesions.血浆的碳-13核磁共振光谱减少了高甘油三酯血症对核磁共振氢谱检测恶性肿瘤的干扰。在乳腺病变患者中的应用。
Breast Cancer Res Treat. 1991 May;18(2):99-110. doi: 10.1007/BF01980972.
9
Study of the ability of proton nuclear magnetic resonance spectroscopy of human plasma to differentiate between controls and breast cancer patients.
Oncology. 1993 Mar-Apr;50(2):110-5. doi: 10.1159/000227159.
10
Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.用于检测恶性肿瘤的质子核磁共振波谱分析评估
Clin Chem. 1988 Mar;34(3):505-11.

引用本文的文献

1
Serum lipids and apolipoproteins in women with breast masses.
Breast Cancer Res Treat. 1995 May;34(2):161-9. doi: 10.1007/BF00665788.

本文引用的文献

1
Statistical approaches to the analysis of receiver operating characteristic (ROC) curves.用于分析接收器操作特性(ROC)曲线的统计方法。
Med Decis Making. 1984;4(2):137-50. doi: 10.1177/0272989X8400400203.
2
1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins.人血浆的核磁共振氢谱研究。脂蛋白共振峰的归属
FEBS Lett. 1987 Jul 13;219(1):239-43. doi: 10.1016/0014-5793(87)81224-3.
3
Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.用于检测恶性肿瘤的质子核磁共振波谱分析评估
Clin Chem. 1988 Mar;34(3):505-11.
4
Measuring the accuracy of diagnostic systems.测量诊断系统的准确性。
Science. 1988 Jun 3;240(4857):1285-93. doi: 10.1126/science.3287615.
5
Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy.通过质子核磁共振光谱法评估鉴定人血浆中恶性疾病存在情况的价值。
Am J Med. 1988 Oct;85(4):528-32. doi: 10.1016/s0002-9343(88)80090-1.
6
Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测。血浆的水抑制质子核磁共振波谱分析。
N Engl J Med. 1986 Nov 27;315(22):1369-76. doi: 10.1056/NEJM198611273152201.
7
Proton spectroscopy of plasma and testing for malignancy.血浆质子光谱分析及恶性肿瘤检测
Lancet. 1987 Aug 1;2(8553):280-1. doi: 10.1016/s0140-6736(87)90871-3.
8
1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms.原发性颅内肿瘤患者血浆的1H和13C核磁共振研究。
J Neurosurg. 1988 Jun;68(6):931-7. doi: 10.3171/jns.1988.68.6.0931.
9
Monitoring of patients with nonseminomatous testicular cancer by nuclear magnetic resonance spectroscopy of plasma.通过血浆核磁共振波谱法监测非精原细胞瘤性睾丸癌患者。
Eur J Cancer Clin Oncol. 1989 Aug;25(8):1141-3. doi: 10.1016/0277-5379(89)90406-9.
10
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.甘油三酯水平对人体血浆质子核磁共振波谱中甲基和亚甲基包络线宽的影响。
N Engl J Med. 1989 Jun 1;320(22):1452-7. doi: 10.1056/NEJM198906013202204.